pyrroles has been researched along with Tumor Lysis Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escudier, B; Gross-Goupil, M; Lassau, N; Massard, C; Mejean, A; Michels, J | 1 |
| Perazzo, F; Rodríguez-Reimúndes, E; Vilches, AR | 1 |
| Davis, ID; Nicholaou, T; Wong, R | 1 |
| Reid, TR; Saylor, PJ | 1 |
4 other study(ies) available for pyrroles and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.
Topics: Angiogenesis Inhibitors; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Tumor Lysis Syndrome; Ultrasonography | 2010 |
[Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib].
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Fatal Outcome; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Tumor Lysis Syndrome | 2011 |
Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Humans; Indoles; Kidney Neoplasms; Pyrroles; Sunitinib; Tumor Lysis Syndrome | 2007 |
Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib.
Topics: Administration, Oral; Antineoplastic Agents; Fatal Outcome; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Indoles; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Tumor Lysis Syndrome | 2007 |